These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3407414)

  • 1. Influence of the combined chemotherapeutic drug tuboprim on drug metabolism.
    Mitcheva M; Staneva-Stoytcheva D
    Acta Physiol Pharmacol Bulg; 1988; 14(1):35-41. PubMed ID: 3407414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of propranolol, pindolol and atenolol after multiple administration in rats on the duration of hexobarbital sleeping time and on the activity of some drug-metabolizing enzyme systems.
    Kastelova A; Stoytchev T
    Acta Physiol Pharmacol Bulg; 1993; 19(4):101-4. PubMed ID: 8203279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE; Evans JS; Holmes D; Baker MT
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of manganese on hepatic drug metabolism in male and female rats.
    Schnell RC; Deimling MJ
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):307-15. PubMed ID: 6709965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol.
    Rush WR; Smith SA; Mulvey JH; Graham DJ; Chaplin MD
    Drug Metab Dispos; 1987; 15(4):571-8. PubMed ID: 2888633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of desoxycorticosterone on the activity of drug-metabolizing enzyme systems.
    Tantcheva L; Stoytchev T
    Acta Physiol Pharmacol Bulg; 1989; 15(2):33-9. PubMed ID: 2801146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of levels of feed restriction on in vivo and in vitro alterations in drug metabolism and associated enzymes.
    Sachan DS; Su PK
    Drug Nutr Interact; 1986; 4(4):363-70. PubMed ID: 3792217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatic drug-metabolizing enzymes by arachidonic acid.
    Pessayre D; Mazel P; Descatoire V; Rogier E; Feldmann G; Benhamou JP
    Xenobiotica; 1979 May; 9(5):301-10. PubMed ID: 115160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of alloxan diabetes on the activity of some mixed function oxidases in male rats.
    Nedjar A; Stoytchev T
    Acta Physiol Pharmacol Bulg; 1990; 16(1):50-5. PubMed ID: 2392953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression of the hepatic cytochrome P-450 monooxygenase system by treatment of mice with the antineoplastic agent 5-azacytidine.
    Gooderham NJ; Mannering GJ
    Cancer Res; 1985 Apr; 45(4):1569-72. PubMed ID: 2579731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human placental extract on hepatic drug metabolizing enzyme.
    Bishayee A; Banerjee KK; Chatterjee M
    Riv Eur Sci Med Farmacol; 1995; 17(1):19-26. PubMed ID: 8545551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats.
    Yamada Y; Nakahara M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1989 Mar; 39(3):356-60. PubMed ID: 2502989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
    Goel A; Dani V; Dhawan DK
    Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Various effects of captopril pharmacokinetics on drug metabolizing systems].
    Markova S
    Eksp Med Morfol; 1989; 28(2):56-9. PubMed ID: 2667945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potentiation of barbiturate-induced narcosis by procarbazine.
    Lee IP; Lucier GW
    J Pharmacol Exp Ther; 1976 Mar; 196(3):586-93. PubMed ID: 1263114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic interactions of promethazine (author's transl)].
    Pfeifer S; Borchert HH; Schuster S; Schulz H
    Pharmazie; 1981 Dec; 36(12):815-8. PubMed ID: 6799969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dietary carbohydrates (alpha-saccharides) on hepatic drug metabolism in male rats.
    Sonawane BR; Coates PM; Yaffe SJ; Koldovsky O
    Drug Nutr Interact; 1983; 2(1):7-16. PubMed ID: 6678749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine.
    Kaul KL; Novak RF
    J Pharmacol Exp Ther; 1987 Oct; 243(1):384-90. PubMed ID: 3668864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
    Atal CK; Dubey RK; Singh J
    J Pharmacol Exp Ther; 1985 Jan; 232(1):258-62. PubMed ID: 3917507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.